Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,080 | 2,179 | 4,239 | 2,742 | 6,018 |
| Marketable Securities | 488 | 2,706 | 3,342 | 3,722 | 507 |
| Receivables | 3,483 | 4,696 | 3,363 | 1,887 | 2,099 |
| Inventories | 8,548 | 8,448 | 8,980 | 7,002 | 6,863 |
| Other current assets | 1,150 | 1,047 | 979 | 1,032 | 1,134 |
| TOTAL | $19,749 | $19,076 | $20,903 | $16,385 | $16,621 |
| Non-Current Assets | |||||
| PPE Net | 13,265 | 13,242 | 13,183 | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 0 | 1,952 |
| Other Non-Current Assets | 2,401 | 1,886 | 1,937 | 2,016 | 2,051 |
| TOTAL | $15,666 | $15,128 | $15,120 | $2,016 | $4,003 |
| Total Assets | $26,807 | $25,839 | $27,900 | $23,508 | $25,837 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 702 | 2,100 | 2,200 | 2,200 | 298 |
| Accounts payable and accrued liabilities | 8,912 | 9,457 | 9,599 | 6,155 | 7,188 |
| Accrued Expenses | 1,633 | 1,844 | 1,864 | 2,388 | 2,121 |
| Other current liabilities | 750 | 750 | 749 | 0 | 223 |
| TOTAL | $11,997 | $14,151 | $14,412 | $10,743 | $9,830 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,445 | 833 | 948 | 979 | 3,067 |
| TOTAL | $5,445 | $833 | $948 | $979 | $3,067 |
| Total Liabilities | $17,442 | $14,984 | $15,360 | $11,722 | $12,897 |
| Shareholders' Equity | |||||
| Common Shares | 67,039 | 66,240 | 66,104 | 160 | 63,172 |
| Retained earnings | -57,695 | -55,696 | -53,754 | -52,844 | -50,376 |
| Other shareholders' equity | 21 | 311 | 190 | 4,173 | 144 |
| TOTAL | $9,365 | $10,855 | $12,540 | $11,786 | $12,940 |
| Total Liabilities And Equity | $26,807 | $25,839 | $27,900 | $23,508 | $25,837 |